drugset / Trial / NCT00882557

Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

NCT00882557

Phase 1 Completed 16 enrolled Merck & Co., Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether daptomycin at a higher dose given during the last 30 minutes of a dialysis session is equal to a lower dose of daptomycin given after a dialysis session.

Timeline

Start
2009-04-29
Primary completion
2009-07-17
Completion
2009-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Daptomycin Other / unclassified 6 mg/kg
Subject Daptomycin Other / unclassified 9 mg/kg